Molecular Formula | C21H32O3 |
Molar Mass | 332.48 |
Density | 1.0834 (rough estimate) |
Melting Point | 172-180°C |
Boling Point | 409.59°C (rough estimate) |
Specific Rotation(α) | 34 º |
Flash Point | 249.7°C |
Solubility | H2O: ≤0.5mg/mL |
Vapor Presure | 1.23E-10mmHg at 25°C |
Appearance | solid |
Color | white to light yellow |
Merck | 6967 |
pKa | 5.28±0.70(Predicted) |
Storage Condition | 2-8°C |
Stability | Stability May be light sensitive. Combustible. Incompatible with strong oxidizing agents. |
Refractive Index | 38 ° (C=1, CHCl3) |
Physical and Chemical Properties | White crystalline powder, odorless. Melting point 173-176 °c (178-180 °c). [Α] D 38 ° (chloroform), insoluble in water, soluble in chloroform, soluble in dioxane, vegetable oil, slightly soluble in ethanol, ether. |
Use | Can promote protein synthesis and inhibit protein alienation, and can reduce blood cholesterol, reduce calcium and phosphorus excretion and reduce bone marrow suppression, promote development and so on |
Risk Codes | R40 - Limited evidence of a carcinogenic effect R63 - Possible risk of harm to the unborn child |
Safety Description | S53 - Avoid exposure - obtain special instructions before use. S22 - Do not breathe dust. S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. S36 - Wear suitable protective clothing. |
WGK Germany | 3 |
RTECS | BV8060000 |
HS Code | 29372900 |
Toxicity | TDLo orl-hmn: 46 mg/kg/14W-I:LIV JAMAAP 240,243,78 |
NIST chemical information | Information provided by: webbook.nist.gov (external link) |
EPA chemical information | Information provided by: ofmpub.epa.gov (external link) |
Use | Intermediate of Canilone. It is a protein anabolic hormone drug, which can promote protein synthesis and inhibit protein heterogenesis, and can reduce blood cholesterol, reduce calcium and phosphorus excretion and reduce bone marrow suppression, promote development, and promote tissue regeneration and granulation formation. It has preventive and antagonistic effects on adrenal hypofunction caused by long-term use of adrenal cortex hormones. It can promote protein synthesis and inhibit protein alienation, and can reduce blood cholesterol, reduce calcium and phosphorus excretion, reduce bone marrow suppression, and promote development. |
production method | the product can be prepared by acetylation, reduction, ring opening, oxidation, hydrolysis, elimination, oxime, rearrangement, hydrolysis, addition, oxidation, hydrolysis, condensation and other multi-step reactions of sisaponin or sisaponin. |
toxic substance data | information provided by: pubchem.ncbi.nlm.nih.gov (external link) |